Surrozen Inc chart

Last update: 2022-12-30
Key statistics and financials
Revenue per share N/A
Dividend & YieldN/A$ (N/A)
Beta N/A
Market capitalization 28.1M
Operating cash flow -55.48M
ESG Scores unknown

Company description

Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration. It is developing tissue-specific antibodies with application across various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system. Its products in pipeline include SZN-043 a tissue-specific R-spondin mimetic for the treatment of severe liver disease; and SZN-1326, a bi-specific full-length human antibody that directly modulates Wnt signaling in target tissue by binding to particular Frizzled and LRP receptors that are expressed in intestinal crypts. Surrozen, Inc. was founded in 2015 and is headquartered in South San Francisco, California.

Sector: Healthcare - Industry: Biotechnology

Financial data

Financial Statements

Cashflow Statement 2019-12-31 2020-12-31 2021-12-31
Change To Liabilities 639k 537k 857k
Total Cashflows From Investing Activities -1.56M -15.07M -77.71M
Net Borrowings
Total Cash From Financing Activities 28.9M 50.05M 124.63M
Change To Operating Activities -1.07M -485k -1.08M
Issuance Of Stock 61k 167k 124.63M
Net Income -24.36M -32.72M -54.65M
Change In Cash 6.29M 5.88M -1.89M
Effect Of Exchange Rate
Total Cash From Operating Activities -21.06M -29.1M -48.81M
Depreciation 2.28M 1.94M 2.07M
Change To Account Receivables
Other Cashflows From Financing Activities
Change To Netincome 1.45M 1.63M 3.99M
Capital Expenditures -1.56M -874k -1.27M

Income Statement 2019-12-31 2020-12-31 2021-12-31
Research Development 19.6M 25.68M 40.18M
Income Before Tax -24.36M -32.72M -54.65M
Net Income -24.36M -32.72M -54.65M
Selling General Administrative 5.5M 7.12M 14.21M
Gross Profit
Ebit -25.11M -32.81M -54.39M
Operating Income -25.11M -32.81M -54.39M
Interest Expense
Income Tax Expense
Total Revenue
Cost Of Revenue
Total Other Income ExpenseNet 744k 91k -257k
Net Income From Continuing Ops -24.36M -32.72M -54.65M
Net Income Applicable To Common Shares -24.36M -32.72M -54.65M

Balance Sheet Statement 2019-12-31 2020-12-31 2021-12-31
Total Liabilities 13.1M 14.77M 27.47M
Total Stockholder Equity -53.83M 47.29M 109.7M
Other Current Liabilities 416k 589k
Total Assets 42.48M 62.06M 137.17M
Common Stock 1k 2k 4k
Other Current Assets
Retained Earnings -55.28M -88M -142.65M
Treasury Stock -119k
Cash 29.1M 34.98M 33.09M
Total Current Liabilities 3.9M 7.28M 13.57M
Other Stockholder Equity -119k
Property, Plant, and Equipment 12.62M 11.39M 9.38M
Total Current Assets 29.41M 50.22M 105.19M
Net Tangible Assets -53.83M 47.29M 109.7M
Net Receivables
Accounts Payable 972k 1.78M 2.72M


Insider Transactions

Here are the insider transactions of stock shares related to Surrozen Inc:

Filer Name Transaction Text Ownership Date Filer Relation Shares
SANTEL DONALD JStock Award(Grant) at price 0.00 per share.D2021-08-11Former30k
BLUTT MITCHELL JONATHANStock Award(Grant) at price 0.00 per share.I2021-08-11Beneficial Owner of more than 10% of a Class of Security3.5M
HAQQ CHRISTOPHERStock Award(Grant) at price 0.00 per share.D2021-08-11Former30k
JARRETT JENNIFERStock Award(Grant) at price 0.00 per share.D2021-08-11Former30k
CONSONANCE LIFE SCIENCESStock Award(Grant) at price 0.00 per share.I2021-08-11Former1.89M
SOFFER BENNYStock Award(Grant) at price 0.00 per share.I2021-08-11Former1.89M
LIVINGSTON KEVIN HAROLDStock Award(Grant) at price 0.00 per share.I2021-08-11Former1.89M
BLUTT MITCHELL JONATHANI2020-12-01Director24k
CONSONANCE LIFE SCIENCESD2020-12-01Beneficial Owner of more than 10% of a Class of Security24k
SOFFER BENNYI2020-12-01Director24k
LIVINGSTON KEVIN HAROLDI2020-12-01Chief Financial Officer24k

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to Surrozen Inc. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on Surrozen Inc

Here is the result of two systematic investment strategies applied to Surrozen Inc. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on Surrozen Inc

The following chart shows the equity curve of the two systematic investment strategies applied to Surrozen Inc:

Surrozen Inc automated entries

The systematic investment strategy that buys the first day of the month would give a performance of 0% on the backtest period.

Performance at glance

Performance

0 %

Latent gain

0.0 $

Invested capital

0.0 $

Annualized return

0.0 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on Surrozen Inc

This is the result of two momentum investment strategies applied to Surrozen Inc. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on Surrozen Inc

The following chart shows all the entries opened by the momentum investment system on Surrozen Inc:

Surrozen Inc momentum entries
  • The first momentum investment strategy would give 0% of return on Surrozen Inc. That represents 0.0$ of latent gain with 0.0$ of employed capital.
  • The second momentum investment strategy would give 0% of return on Surrozen Inc. That represents 0.0$ of latent gain with 0.0$ of employed capital.
Performance at glance (1Q Momentum)

Performance

0 %

Latent gain

0.0 $

Invested capital

0.0 $

Annualized return

-0.0 %
Performance at glance (2Q Momentum)

Performance

0 %

Latent gain

0.0 $

Invested capital

0.0 $

Annualized return

-0.0 %

Momentum equity curve on Surrozen Inc

The following chart shows the equity curve of the two momentum strategies applied to Surrozen Inc:

Surrozen Inc momentum equity

Note: the dividends potentially given by Surrozen Inc are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Surrozen Inc

The following chart shows the employed capital evolution of the two momentum strategies on Surrozen Inc since the beginning:

Surrozen Inc

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Buy the dip strategy result on Surrozen Inc

Buy the dip entry openings on Surrozen Inc

Surrozen Inc

The performance achieved by the robo-advisor on Surrozen Inc is 0%. That represents 0.0$ of latent gain with 0.0$ of employed capital. The following chart shows Surrozen Inc stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of Surrozen Inc, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

0 %

Latent gain

0.0 $

Invested capital

0.0 $

Annualized return

-0.0 %

Equity curve of the strategy applied to Surrozen Inc

The following chart shows the result of the investment strategy applied to Surrozen Inc:

Surrozen Inc

Note: the dividends potentially given by Surrozen Inc are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Surrozen Inc

The following chart shows the employed capital evolution since the beginning of the investment strategy on Surrozen Inc:

Surrozen Inc

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on Surrozen Inc

In this section, I will compare the three previous investment strategies applied to Surrozen Inc.

Equity curve comparison on Surrozen Inc

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

Surrozen Inc investment strategy comparison

Employed capital comparison on Surrozen Inc

Surrozen Inc investment comparison

Performance comparison on Surrozen Inc

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment 0% 0.0$ 0.0$ 0.0%
Momentum 1 quarter 0% 0.0$ 0.0$ -0.0%
Momentum 2 quarters 0% 0.0$ 0.0$ -0.0%
Non-directional 0% 0.0$ 0.0$ -0.0%
Annualized return comparison

Automatic investment

0.0 %

Momentum 1Q

-0.0 %

Momentum 2Q

-0.0 %

Non-directional

-0.0 %

Correlated stocks

Here are the most positively and negatively correlated stocks with Surrozen Inc:

Positive correlations

Most correlated stocks this year


Most correlated stocks last 3 months

Negative correlation

Most negatively correlated stocks this year


Most negatively correlated stocks last 3 months

Note: The algorithm computes the probability of correlation between Surrozen Inc and the other stocks. There may be false positives or some missing correlated stocks. If the price of Surrozen Inc does not vary for 36 weeks, the correlation calculation result will be wrong.


Company information

Company name Surrozen Inc
Country United States
City South San Francisco
Address 171 Oyster Point Boulevard
Phone 650 489 9000
Website www.surrozen.com
FullTime employees 83
Industry Biotechnology
Sector Healthcare
Exchange XNAS
Ticker SRZN
Market www.nasdaq.com

Surrozen Inc ESG Scores

Environment scores

Environment ESG Factors Scores
Environment Score 0
Peer Environment Performance unknown
Environment Percentile unknown
Palm Oil unknown
Nuclear unknown
Fur Leather unknown
GMO unknown
Coal unknown
Pesticides unknown
Animal Testing unknown

Social scores

Social ESG Factors Scores
Social Score 0
Peer Social Performance unknown
Social Percentile unknown
Highest Controversy unknown
Peer Highest Controversy Performance unknown
Adult unknown
Gambling unknown
Alcoholic unknown
Tobacco unknown
Catholic unknown
Controversial Weapons unknown
Small Arms unknown
Military Contract unknown
Peer Count unknown

Related Controversy:


Governance scores

Governance ESG Factors Scores
Governance Score 0
Peer Governance Performance unknown
Governance Percentile unknown

ESG at glance
Total ESG Scores: unknown
Environment Score: 0
Social Score: 0
Governance Score: 0

ESG Performance: unknown

Peer Group: unknown

Peer Esg Score Performance: unknown

Rating Year: unknown

Rating Month: unknown

Max Age: unknown

Percentile: unknown